Seminar 2026

AI is moving rapidly from pilot use cases into core clinical trial decision-making, but most organizations are still not structured to capture consistent, scalable value. That gap is showing up in fragmented data flows, unclear regulatory pathways, and difficulty demonstrating ROI across the trial lifecycle. Top executives from top global pharma will discuss: What decision intelligence in clinical trials looks like in practice and where it is driving measurable impact today How AI is being integrated (or failing to integrate) across study design, site selection, enrolment, and operations Where regulatory readiness is evolving and how teams are navigating validation, compliance, and audit expectations What it takes organizationally to move from experimental pilots to scaled, ROI-driven AI adoption in clinical development